Literature DB >> 15504702

Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.

Lisa D Cabrita1, Stephen P Bottomley.   

Abstract

The release of sequence data, particularly from a number of medically and biotechnologically important genomes, is increasing in an exponential fashion. In light of this, elucidating the structure and function of proteins, particularly in a "high throughput" manner, is an important quest. The production of recombinant proteins however is not always straightforward, with a number of proteins falling prey to low expression problems, a high susceptibility to proteolysis and the often despised production of inclusion bodies. Whilst expression as inclusion bodies can often be advantageous, their solubilization and renaturation is often a time consuming and empirical process. In this review, we aim to outline some of the more common approaches that have been applied to a variety of proteins and address issues associated with their handling.

Mesh:

Substances:

Year:  2004        PMID: 15504702     DOI: 10.1016/S1387-2656(04)10002-1

Source DB:  PubMed          Journal:  Biotechnol Annu Rev        ISSN: 1387-2656


  25 in total

1.  Experimental optimization of protein refolding with a genetic algorithm.

Authors:  Bernd Anselment; Danae Baerend; Elisabeth Mey; Johannes Buchner; Dirk Weuster-Botz; Martin Haslbeck
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

2.  A simplified method for the efficient purification and refolding of recombinant human TRAIL.

Authors:  Zhenjiang Zhang; Su Bin Hahn; Thong M Cao; Michael R King
Journal:  Biotechnol Prog       Date:  2020-05-11

3.  Combinatorial Domain Hunting: An effective approach for the identification of soluble protein domains adaptable to high-throughput applications.

Authors:  Stefanie Reich; Loretto H Puckey; Caroline L Cheetham; Richard Harris; Ammar A E Ali; Uma Bhattacharyya; Kate Maclagan; Keith A Powell; Chrisostomos Prodromou; Laurence H Pearl; Paul C Driscoll; Renos Savva
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

4.  Enhancing the stability and solubility of TEV protease using in silico design.

Authors:  Lisa D Cabrita; Dimitri Gilis; Amy L Robertson; Yves Dehouck; Marianne Rooman; Stephen P Bottomley
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

5.  Nicotinamide phosphoribosyltransferase purification using SUMO expression system.

Authors:  Trivikram R Molugu; Radu C Oita; Udeep Chawla; Sara M Camp; Michael F Brown; Joe G N Garcia
Journal:  Anal Biochem       Date:  2020-01-23       Impact factor: 3.365

6.  Production of hepatopoietin Cn in high-cell-density cultures of recombinant Escherichia coli and detection of its antioxygen activity.

Authors:  Yang Liu; Xiao-Li Li; Dong-Dong Zhang; Qiang Wang; Yong Liu; Dong-Mei Liu; Chu-Tse Wu; Chun-Ping Cui
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

7.  Soluble expression and purification of Brucella cell surface protein (BCSP31) of Brucella melitensis and preparation of anti-BCSP31 monoclonal antibodies.

Authors:  Lei Zhang; Xing An Wu; Fang Lin Zhang; Cui Hong An; Yang Xin Sun; Wen Tao Bai; Zhi Kai Xu
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

8.  Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method.

Authors:  Zhong Yang; Linlin Zhang; Yan Zhang; Ting Zhang; Yanye Feng; Xiuxiu Lu; Wenxian Lan; Jufang Wang; Houming Wu; Chunyang Cao; Xiaoning Wang
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

9.  Expression plasmids and production of EGFP in stably transfected Acanthamoeba.

Authors:  Erik Bateman
Journal:  Protein Expr Purif       Date:  2009-10-28       Impact factor: 1.650

10.  Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva.

Authors:  Nouha Chahed Bel-Ochi; Aïda Bouratbine; Mohamed Mousli
Journal:  Clin Vaccine Immunol       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.